Business Wire

STRATEC Consumables and Vortex Biosciences Announce Manufacturing Partnership

Jaa

Vortex BioSciences, a NetScientific portfolio company and STRATEC Consumables GmbH, a wholly owned subsidiary of STRATEC Biomedical AG, Birkenfeld, Germany, announced the signing of a supply agreement covering a customized microfluidic polymer chip. This chip is a key component of the VTX-1 instrument, an automated liquid biopsy platform which provides a simple, label free isolation of circulating tumor cells directly from a tube of blood.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181106005452/en/

Microfluidic polymer chip by STRATEC Consumables (Photo: Business Wire)

Microfluidic polymer chip by STRATEC Consumables (Photo: Business Wire)

This microfluidic research platform was developed in Dino Di Carlo’s Lab at UCLA which has been successfully transferred to the commercial VTX-1 Liquid Biopsy System. The label-free microfluidic device utilizes inertial lift and laminar microvortices, allowing larger and more deformable cancer cells to be collected while smaller cells such as red and white blood cells pass through. With this technology, Vortex BioSciences is offering the best available liquid biopsy platform for CTC isolation and collection from patient samples.

Adapting the design to a commercial scale microfluidic device can be guaranteed at STRATEC at their ISO-13485 certified facility in Salzburg, Austria. By offering technical capabilities from initial concept through mass manufacturing, STRATEC can ensure silicon precision in plastics and high reproducibility.

“We are delighted to be partnering with STRATEC to fabricate our microfluidic chip. This chip is the essential element of our label-free technology to enable an efficient and fully-automated patient sample processing”, said Bob Englert, Chief Executive Officer at Vortex Biosciences. “The transfer from a variable research-level polymer prototype to a robust and reproducible plastic commercial chip is a key part of a successful transfer of technology to the market. This ultimately enables CTCs to be more widely used in cancer research and become part of the standard of care”, said Elodie Sollier, Chief Scientific Officer and co-founder at Vortex Biosciences.

“Bringing the Vortex chip into mass-manufacturing was a very exciting project for us. Vortex is inspiring both in its benefit to the constantly maturing liquid biopsy market, as well as in their balance of being science-driven but focused on commercialization. It is exactly with companies like Vortex where we see our big strength in actively participating in the transformation process of a new technology from a lab idea, or early prototypes to an actual medical product, eventually fit for the IVD market”, says Maximilian Pitzek, Project Manager at STRATEC Consumables.

About Vortex BioSciences

Vortex Biosciences is a cancer research and diagnostics company that integrates cancer biology, microfluidic engineering and informatics to develop tools for isolating and characterizing circulating tumor cells. The Vortex VTX-1 instrument harvests intact circulating tumor cells from whole blood samples for use in downstream research and potentially clinical applications such as patient stratification in clinical trials, monitoring disease progression and drug treatment effectiveness. With a mission to enable noninvasive diagnosis of cancer and real-time monitoring throughout a patient’s treatment, Vortex is at the forefront of accelerating cancer research and improving patient outcomes. Vortex is a core subsidiary of NetScientific plc, a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercializing technologies that significantly improve the health and well-being of people with chronic diseases.

For more information, visit www.vortexbiosciences.com.

About STRATEC

STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers sample preparation solutions, integrated laboratory software, and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain – from development to design and production through to quality assurance.

The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks, and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies.

For more information please visit www.stratec.com/solutions/consumables

Contact information

Vortex BioSciences
Bob Englert, CEO
Vortex Biosciences Inc
bob@vortexbiosciences.com
or
STRATEC Consumables
Ricarda Pichler
STRATEC Consumables GmbH
+ 43 6248 880 8919
r.pichler@stratec.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

L’Oréal Rewards Social Initiatives Led by Dermatologists at World Congress of Dermatology in Milan20.6.2019 12:23:00 EESTTiedote

In partnership with the International League of Dermatological Societies (ILDS) and the 24th World Congress of Dermatology (WCD), L’Oréal announced the laureates of the third International Awards for Social Responsibility in Dermatology: “Caring to Inspire Skin Confidence”. This aims to reward social initiatives led by dermatologists, improving patients’ physical and psychological well-being, self-esteem, social integration and skin health, and enabling patients to re-engage socially. Brigitte Liberman, President of L’Oréal’s Active Cosmetics Division, said: “Social responsibility is a priority for L’Oréal and we are proud to partner with the ILDS and the WCD to reward iconic dermatologists having positive actions on people’s lives”. Professor Harvey Lui, President of the ILDS, added: “Beyond the day-to-day activities of dermatologists in managing patients with skin issues, there is a vital social role, which is exemplified through our partnership for these awards and lies at the heart

First deployment of open-standard Identity Management interface OSIA in DRC20.6.2019 11:45:00 EESTTiedote

IDEMIA, the global leader in Augmented Identity, in partnership with CIVIPOL, the technical cooperation operator of the French Ministry of the Interior, DIGITECH, a leading provider of paperless Civil Registry solutions, UNFPA, the United Nations Population Fund and CARITAS, a confederation of 165 Catholic relief, development and social service organizations, announces the first deployment of the open-standard Identity Management interface OSIA in the Democratic Republic of Congo (DRC). This World Bank funded project aims to register 2.4 million children and produce 600,000 birth certificates. The consortium led by CIVIPOL supports the ambitious goal set out by the United Nations General Assembly “One ID for all by 2030.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190620005047/en/ Credits : IDEMIA The consortium focusses on two project streams: the first stream concentrates on the enhancement of the current Civil Registr

Wrap.co Releases The World’s First SaaS Software in Historic Global Announcement20.6.2019 08:00:00 EESTTiedote

Wrap.co, The Mobile Card-Based Innovator™, released The World’s First SaaS Software today—highlighting the ease by which their card-based mobile engagement and conversion platform conveys complex ideas quickly to a global audience poised to consume content at “The Speed of Thumb™”. “According to Danny Hillis in his book, The Pattern on The Stone, any series of yes/no decisions can be considered software—thus,” said Christopher Bruno, CEO of Wrap.co, “we chose pre-historic Irish engravings—ancient when the Pyramids were built—to illustrate how Wrap can allow a mobile user unacquainted with a technical topic to flip through selected content to arrive at hoped-for conclusion in mere seconds—in this case: the belief that an animated engraving represents the 19-year cycle of the moon.” Bruno chose the so-called “Calendar Stone of Knowth” in County Meath, Ireland, as the subject matter for their first global presentation of Wrap.co’s revolutionary carrier-grade card-based communication platf

Algorand Foundation Marks New Chapter in Global Economics with Inaugural Auction19.6.2019 23:56:00 EESTTiedote

The Algorand Foundation announced today the successful completion of its inaugural Algo auction, marking the launch of the Algorand platform and its original economic model that uses a unique combination of consensus-driven blockchain technology and economic incentives to ensure absolute fairness and broad participation in a new Borderless Economy. The auction brings Algos, the native token of the Algorand blockchain platform, into market circulation for the first time. Originally scheduled to last for more than five hours, the auction sold out in under four hours, due to oversubscribed demand from a large group of global participants. The Dutch Auction mechanism ensured the market, not the seller, set the price of the offering and that each participant paid the same price per Algo. The Algorand platform is the first public, permissionless pure proof-of-stake blockchain protocol that solves the “blockchain trilemma” of achieving scalability, security and true decentralization all at on

Cooper & Turner Announces Potential Combination with Beck Industries19.6.2019 22:32:00 EESTTiedote

Andaray (Holdings) Limited and its direct and indirect subsidiaries (“Cooper & Turner”) have entered into an agreement with Beck Industries (“Beck”) for potential combination of the two groups. The contemplated combined entity aims to be the first truly global manufacturer of safety critical fasteners, together supporting a broader range of industries – including renewable energy, tunneling, construction, rail, heavy equipment, downstream oil & gas, power generation and nuclear, among others. Headquartered in Sheffield, England, Cooper & Turner serves a global customer base with manufacturing and distribution operations across the European Union, China and North America. This worldwide network enables Cooper & Turner to offer a seamless, one-stop shop solution for industrial fasteners that meet the highest levels of quality. Beck, a France-based manufacturer and distributor of fully certified, high-security bolting components, has built a global operation that complements and expands t

Tinubu Square Appoints Sophie Riottot as Group Sales Director19.6.2019 20:02:00 EESTTiedote

Tinubu Square, a leading provider of credit insurance, surety and trade finance solutions, has announced the appointment of Sophie Riottot as Group Sales Director. This is a strategic engagement for the company, which is restructuring its sales approach to reinforce its rapid global growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190619005634/en/ Sophie Riottot, new Group Sales Director at Tinubu Square (Photo: Business Wire) Sophie Riottot brings a wealth of experience to Tinubu Square. She joins the company from Dhatim, a French start-up specializing in AI-powered invoice services, where she was responsible for sales strategy and partnership development. Prior to this, she was with Microsoft for over 17 years, in a variety of prominent sales and management positions, including Head of Finance in the Services Division. As a member of the executive committee at Tinubu Square, Sophie will be responsible for spearheadin

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme